Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT03484299
What this trial is testing

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
University of Louisville 20
Not applicableActive Not RecruitingNCT03583528
What this trial is testing

DOTATOC PET/CT for Imaging NET Patients

Who this might be right for
Neuroendocrine TumorsInsulinomaGastrinoma+13 more
British Columbia Cancer Agency 800
Early research (Phase 1)WithdrawnNCT00025532
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University of California, San Francisco
Not applicableEnded earlyNCT00767234
What this trial is testing

Permission to Collect Blood Over Time for Research

Who this might be right for
Pancreatic CancerGastrointestinal NeoplasmsColon Rectal Cancer Adenocarcinoma+11 more
Stanford University 104
Not applicableUnknownNCT02436564
What this trial is testing

In Vitro Models of Liver and Pancreatic Cancer

Who this might be right for
CholangiocarcinomaHepatocellular CarcinomaPancreatic Neoplasm
Cambridge University Hospitals NHS Foundation Trust 75
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Study completedNCT00003760
What this trial is testing

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center at San Antonio 3
Testing effectiveness (Phase 2)Ended earlyNCT04975516
What this trial is testing

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8Recurrent Pancreatic Adenocarcinoma+1 more
Mayo Clinic 2
Testing effectiveness (Phase 2)Study completedNCT00003546
What this trial is testing

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 43
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Large-scale testing (Phase 3)Study completedNCT00075686
What this trial is testing

S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 766
Testing effectiveness (Phase 2)Study completedNCT01019382
What this trial is testing

The Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University Hospitals, Leicester 50
Not applicableLooking for participantsNCT06649474
What this trial is testing

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

Who this might be right for
Pancreatic CancerResectable Pancreatic AdenocarcinomaAdenocarcinoma+3 more
University Hospital, Clermont-Ferrand 100
Testing effectiveness (Phase 2)Study completedNCT00004190
What this trial is testing

Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 59
Not applicableStudy completedNCT05292859
What this trial is testing

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

Who this might be right for
Gynecologic CancerColorectal CancerPancreatic Cancer+7 more
Alaunos Therapeutics 7
Testing effectiveness (Phase 2)Looking for participantsNCT04657068
What this trial is testing

ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerOvarian Cancer+6 more
Artios Pharma Ltd 542
Testing effectiveness (Phase 2)WithdrawnNCT03778879
What this trial is testing

Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B

Who this might be right for
Adenocarcinoma of the PancreasPancreas Cancer
Alan Katz
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Large-scale testing (Phase 3)Study completedNCT03126435
What this trial is testing

EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX

Who this might be right for
Metastatic Pancreas CancerLocally Advanced Pancreatic CancerPancreatic Adenocarcinoma
SynCore Biotechnology Co., Ltd. 218
Large-scale testing (Phase 3)Looking for participantsNCT01954992
What this trial is testing

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Eleison Pharmaceuticals LLC. 480
Next Page